Cargando…

Long-Term Outcome of Patients with TPO Mutations

Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobias, Leraz, Elias-Assad, Ghadir, Khayat, Morad, Admoni, Osnat, Almashanu, Shlomo, Tenenbaum-Rakover, Yardena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432017/
https://www.ncbi.nlm.nih.gov/pubmed/34501348
http://dx.doi.org/10.3390/jcm10173898
_version_ 1783751066725122048
author Tobias, Leraz
Elias-Assad, Ghadir
Khayat, Morad
Admoni, Osnat
Almashanu, Shlomo
Tenenbaum-Rakover, Yardena
author_facet Tobias, Leraz
Elias-Assad, Ghadir
Khayat, Morad
Admoni, Osnat
Almashanu, Shlomo
Tenenbaum-Rakover, Yardena
author_sort Tobias, Leraz
collection PubMed
description Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans.
format Online
Article
Text
id pubmed-8432017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84320172021-09-11 Long-Term Outcome of Patients with TPO Mutations Tobias, Leraz Elias-Assad, Ghadir Khayat, Morad Admoni, Osnat Almashanu, Shlomo Tenenbaum-Rakover, Yardena J Clin Med Article Introduction: Thyroid peroxidase (TPO) deficiency is the most common enzymatic defect causing congenital hypothyroidism (CH). We aimed to characterize the long-term outcome of patients with TPO deficiency. Methods: Clinical and genetic data were collected retrospectively. Results: Thirty-three patients with primary CH caused by TPO deficiency were enrolled. The follow-up period was up to 43 years. Over time, 20 patients (61%) developed MNG. Eight patients (24%) underwent thyroidectomy: one of them had minimal invasive follicular thyroid carcinoma. No association was found between elevated lifetime TSH levels and the development of goiter over the years. Conclusions: This cohort represents the largest long-term follow up of patients with TPO deficiency. Our results indicate that elevated TSH alone cannot explain the high rate of goiter occurrence in patients with TPO deficiency, suggesting additional factors in goiter development. The high rate of MNG development and the risk for thyroid carcinoma indicate a need for long-term follow up with annual ultrasound scans. MDPI 2021-08-30 /pmc/articles/PMC8432017/ /pubmed/34501348 http://dx.doi.org/10.3390/jcm10173898 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tobias, Leraz
Elias-Assad, Ghadir
Khayat, Morad
Admoni, Osnat
Almashanu, Shlomo
Tenenbaum-Rakover, Yardena
Long-Term Outcome of Patients with TPO Mutations
title Long-Term Outcome of Patients with TPO Mutations
title_full Long-Term Outcome of Patients with TPO Mutations
title_fullStr Long-Term Outcome of Patients with TPO Mutations
title_full_unstemmed Long-Term Outcome of Patients with TPO Mutations
title_short Long-Term Outcome of Patients with TPO Mutations
title_sort long-term outcome of patients with tpo mutations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432017/
https://www.ncbi.nlm.nih.gov/pubmed/34501348
http://dx.doi.org/10.3390/jcm10173898
work_keys_str_mv AT tobiasleraz longtermoutcomeofpatientswithtpomutations
AT eliasassadghadir longtermoutcomeofpatientswithtpomutations
AT khayatmorad longtermoutcomeofpatientswithtpomutations
AT admoniosnat longtermoutcomeofpatientswithtpomutations
AT almashanushlomo longtermoutcomeofpatientswithtpomutations
AT tenenbaumrakoveryardena longtermoutcomeofpatientswithtpomutations